LXRX Next Earnings Date Notes

— Lexicon Pharmaceuticals (LXRX) is a biopharmaceutical company focused on the development & commercialization of innovative therapies for treating serious chronic diseases, with a primary emphasis on cardiometabolic & endocrine disorders. The company's lead asset is INPEFA—recently FDA-approved for the treatment of heart failure—which represents a crucial driver of Lexicon's near- and long-term growth prospects. As you prepare for the upcoming earnings call, monitor Rx (prescription) growth trends, INPEFA's adoption rates, net product revenues, sales & marketing spend, and management's updated guidance regarding market penetration and commercialization timelines. Pipeline progress for investigational therapies, cash runway, and strategic partnership announcements are also key metrics, since these indicate Lexicon's ability to sustain R&D and manage future launches. Ultimately, listen for management commentary on payer access, competitive positioning vs. other SGLT2 inhibitors, and progress toward profitability. By tracking these metrics & company priorities, you’ll be better equipped to assess Lexicon's execution and its overall trajectory within a highly competitive cardiometabolic therapeutic space. The next projected earnings date for LXRX is 8/5/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

LXRX Next Earnings Date FAQ

On this page we presented the LXRX Next Earnings Date information for Lexicon Pharmaceuticals along with recent past earnings dates. For Q1 of 2026, LXRX reported earnings of 0.000/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, LXRX reported earnings of -0.040/share, with the earnings report taking place on 3/5/2026. For Q3 of 2025, LXRX reported earnings of -0.040/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, LXRX reported earnings of 0.010/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, LXRX reported earnings of -0.070/share, with the earnings report taking place on 5/13/2025. Based on these past earnings dates, the projected next earnings date for LXRX is 8/5/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Lexicon Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Lexicon Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Lexicon Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next LXRX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up LXRX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the LXRX next earnings date.